更新:在莫德纳遭拒后,美国卫生与公众服务部支持FDA驳回mRNA流感疫苗申请的决定。
UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
生物技术与制药领域的最新动态
UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
Takeda downsizes Boston footprint amid consolidation effort
Scott Gottlieb Buys 200 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) EVP Gianluca Pettiti Sells 400 Shares - MarketBeat
Lonza Group (OTCMKTS:LZAGY) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat
Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.8% Yield - StreetInsider
Own Agilent stock by March 31? A $0.255 cash payout is coming in April - Stock Titan
FDA may consider Moderna's flu vaccine in a narrower group
Whole-genome sequencing in the UK and Europe, with Mark Robinson - pharmaphorum
Former AstraZeneca senior staff charged with illegal trade in China
‘The only thing that saves us is data’: Allogeneic CAR-T biotechs fight for relevance as industry moves on
Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant - marketscreener.com
Financings for Feb. 11, 2026
In the clinic for Feb. 11, 2026
Other news to note for Feb. 11, 2026
Madrigal adds siRNA approach to MASH pipeline in $4.4B Ribo deal
NIH ends Xarelto arm of stroke trial due to safety, futility
Prasad overruled vaccine review team, office director on Moderna flu shot
Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Coll - PharmiWeb.com
After CEO departs, CSL details profit crash, $1.1B impairment costs